Indianapolis-based Lilly has battled a flood of lawsuits claiming Zyprexa causes weight gain, diabetes or high blood sugar and that Lilly has failed to warn about those risks.
In the last two years, Lilly has settled 28,500 Zyprexa cases. In two previous rounds of settlements, Lilly agreed to pay out $1.2 billion. The company still faces Zyprexa liability lawsuits from about 750 patients.
In 2006, Zyprexa totaled $4.4 billion in worldwide sales.